Hubei Bio-pharmaceutical Industrial Technological Institute Inc.

This early-stage trial tests a new tablet called HW241045 in 102 healthy volunteers to see if it is safe and how the body processes it. The drug is being developed for idiopathic pulmonary fibrosis, a lung-scarring disease. The study is randomized, double-blind, and placebo-contr…

This study tests an ointment called HW211026 in 80 adults with actinic keratosis, rough skin patches caused by sun damage. The goal is to see if the ointment can completely clear these lesions on the face. Participants will use the ointment and be monitored for safety and effecti…

This study tests an experimental drug called HW091077 for people with a chronic cough that lasts a year or more and doesn't improve with standard treatment. About 180 adults in China will receive either the drug or a placebo daily for 4 weeks. Researchers will measure cough frequ…

This early-stage study tests a new drug, HW252001, in 98 healthy adults aged 18 to 55. The goal is to check the drug's safety and how the body processes it, not to treat any disease. Participants will receive either the drug or a placebo, and researchers will monitor for side eff…